(Q48399893)

English

Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma.

scientific article published on 20 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

0 references

author name string

Dorothee Koch

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

Thomas Hundsberger

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

Stephan Boor

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

Bernd Kaina

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

publication date

20 September 2006

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

82

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

85-89

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

https://scigraph.springernature.com/pub.10.1007/s11060-006-9244-8

0 references

Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of O6-methylguanine-DNA methyltransferase by glucose-conjugated inhibitors: comparison with nonconjugated inhibitors and effect on fotemustine and temozolomide-induced cell death

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability and regulation of O6-alkylguanine-DNA alkyltransferase

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repair of O(6)-alkylguanine by alkyltransferases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA repair in resistance to alkylating anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preassembled method for insertion of Ommaya reservoir

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

O6-methylguanine-DNA methyltransferase activity in human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MGMT: its role in cancer aetiology and cancer therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

O6-methylguanine-DNA methyltransferase activity in breast and brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17031555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-006-9244-8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/17031555

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48399893&oldid=1400695866"